Insight
- Our client, a clinical-stage biotech company, were seeking to secure broad investment to further support development of their first-in-class rheumatoid arthritis therapy
- Highlighting the therapy’s novel mechanism of action and potential to address persistent unmet patient needs within a crowded and well-established therapeutic market was a key strategic communication point for this lay audience
Implement
Calling upon our proven network of experts, we partnered with a specialist animation studio to design and produce a mode of action animation that:
- Simplified and elevated communication of a complex, first-in-class mechanism of action
- Differentiated the asset from competing therapies by clearly articulating its unique scientific value
- Enhanced engagement and recall through a high-impact, premium multimedia experience
- Equipped the client with versatile visual assets that extended the value and reach of the materials
Impact
- Our client was delighted with the visualisation and detailed rendering of their drug and its mechanism of action
Iterate
- Visuals from the MOA video were used as assets on the client’s website and throughout investor materials
- The therapy has progressed through Phase II clinical trial testing for rheumatoid arthritis and is now being investigated in other relevant indications
